Abstract: A nozzle assembly that includes an outlet conduit that exhaust to the environment, a rear sub-chamber, a liquid inlet that opens into the rear sub-chamber, a front sub-chamber in fluid communication with both the outlet conduit and the rear sub-chamber and a dividing member disposed between the front and rear sub-chambers. The dividing member includes fluid passages that provide fluid communication between the front and rear sub-chambers. The nozzle also includes an air inlet conduit configured to deliver a pressurized supersonic air stream into the front sub-chamber. The parts of the nozzle assembly are configured to give rise to first, second and third atomization stages that respectively occur in the rear sub-chamber, the front sub-chamber and at the outlet conduit.

Abstract: The present disclosure relates to utilizing a distributed data management system to provide improved data management, redundancy, and reliability in distributed directory systems. To illustrate, a distributed data management system improves existing distributed directory systems by relocating and distributing the management of data records from a centralized cache device to the backend storage partition devices. In this manner, the backend storage partition devices become responsible for automatically pushing data record metadata and changes to the centralized cache device, which only passively redirects the incoming requests to the proper backend storage partition devices. Additionally, the backend storage partition devices automatically resolve conflicts and restore lost data if the centralized cache device or a backend storage partition device suffers from faults or device failures.

Abstract: The present invention discloses a design for a measurement device with improved power measurement accuracy, involving the measurement of the temperature using a highly accurate device that can be installed coupled to the protectors, the device comprising: an essentially rectangular parallelepiped-shaped casing with a plurality of slots in the lateral surfaces, one or more openings, and at least one electrical connection rod; a motherboard (PCB) on the inside of the casing, comprising a first face having at least one Shunt resistor and its own power supply, and a second face, opposite the first face, having—a communication module consisting of a microcontroller that is connected to the measurement module, —a temperature sensor disposed on the second face (PCB) and on the side opposite the Shunt resistor, and—electrically isolated communication ports; and an analogue-to-digital converter.

Abstract: A system (100) for managing incoming calls in a user's mobile device (3) while using a user's virtual reality, VR, device (1), comprising a user's mobile device (3) comprising a SIM card associated to a Mobile Subscriber Integrated Services Digital Number, MSISDN, the SIM card associated to a mobile carrier from an IP Multimedia. Subsystem, IMS, network (6), a user's virtual reality, VR, device (1) comprising computing means (2) to perform a pairing process between the mobile device (3) and the user's VR device (1) and managing incoming calls, an authentication module (4) configured to authenticate the user's mobile device (3), wherein authenticate means that the VR user (A) is in possession of the user's mobile device (3) comprising the SIM card; and a Web Real Time Communications Gateway, WebRTC GW(5) connected to the IMS network (6) of the mobile carrier and configured to translate IMS signaling into WebRTC signaling.

Abstract: A method to obtain a composition comprising an enriched population of functional mesenchymal stem cells for hypothermic transport and local administration of said enriched population of functional mesenchymal stem cells in therapy. Finally also described is the use of said enriched population of functional mesenchymal stem cells, and compositions comprising them, obtained by the described method, in autologous or allogeneic treatment of diseases susceptible to mesenchymal stem cell therapy, either by local or systemic treatments, and more particularly in the treatment of osteoarticular diseases such as degenerative disc disease, osteoarthritis, and bone repair; in lupus erythematosus, graft-versus-host disease, and other autoimmune diseases; in peripheral vascular insufficiency and other cardiovascular diseases.

Abstract: In an embodiment, a photoinitiation apparatus includes: a set of illumination sources or elements configured for outputting optical energy; a body structure having a proximal body structure portion confining a proximal volume of explosive medium, an intermediate body structure portion confining an intermediate volume of explosive medium, and a distal body structure portion confining a distal volume of explosive medium, wherein the proximal volume of explosive medium is optically coupled to portions of the first volume of explosive medium, at least one of the proximal volume of explosive medium and the distal volume of explosive medium is a tertiary explosive medium, and (a) the body structure does not carry a primary explosive composition and does not carry a secondary explosive composition, and/or (b) each of the proximal, intermediate, and distal volumes of explosive media has an initiation sensitivity that is less than cyclotrimethylenetrinitramine (RDX) based explosive compositions.

Abstract: The invention relates to a method which comprises making a hole in a metallic support of an absorber tube, putting a vacuum pump in fluid communication with the chamber of the absorber tube by means of the hole, actuating the vacuum pump to generate a vacuum in the chamber until reaching a predetermined vacuum threshold, and introducing an inert gas inside the chamber and performing a plurality of sweeps with said inert gas, removing hydrogen from the chamber, allowing to thus reduce or remove the accumulation of hydrogen in said chamber, such that, as a result, at least part of the hydrogen absorption capacity of the getter material is recovered.

Abstract: Rear suspension device for a bicycle with three pivots, each with an axis of rotation an axial compression shock absorber, a linkage unit, a sensor unit and a magnet. The axes of rotation are parallel to each other and the axial compression shock absorber has a first end attached to the first pivot and a second end attached to the second pivot. The linkage unit is attached to the second pivot and the third pivot and rotates about the second and third axis of rotation. The sensor unit is on a surface of the linkage unit and comprises a Hall-effect sensor located in a plane perpendicular to the third axis of rotation and located at a distance d1 from the third axis of rotation. The first magnet is: a cylindrical or cylindrical shell magnet having an axis of rotational symmetry which is perpendicular to the parallel faces thereof; or a prism-shaped magnet comprising two polygonal parallel faces and an axis of rotational symmetry which is perpendicular to said parallel faces.

Abstract: Provided in the present disclosure is a mixture, comprising 86-89 wt % of a methionine hydroxy analog and an oligomer thereof, more than 99.95 wt % being a monomer, dimer and trimer, and the ratio of monomer:dimer:trimer by weight being 77-80:18.5-19.5:3-4; 9.2-13.5 wt % of water; and less than 0.5 wt % of ammonium sulfate and ammonium bisulfate. The viscosity of the mixture at 10° C. is lower than 200 mPa·s. Further provided is a method for processing a mixture containing a methionine hydroxy analog and an oligomer thereof.

Abstract: Automotive noise attenuating trim part comprising at least a porous layer whereby the porous layer comprises at least one closed container partly filled with loose particles, whereby the closed container comprises a contact surface formed by a film for contacting a vibrating surface of the vehicle and whereby the surface of the film opposite the contact surface is in contact with at least part of the loose particles, such that the film can transfer vibrational energy from the vibrating surface to the loose particles inside the container.

Abstract: In an embodiment, a photoinitiation apparatus includes: a set of illumination sources or elements configured for outputting optical energy; a body structure having a proximal body structure portion confining a proximal volume of explosive medium, an intermediate body structure portion confining an intermediate volume of explosive medium, and a distal body structure portion confining a distal volume of explosive medium, wherein the proximal volume of explosive medium is optically coupled to portions of the first volume of explosive medium, at least one of the proximal volume of explosive medium and the distal volume of explosive medium is a tertiary explosive medium, and (a) the body structure does not carry a primary explosive composition and does not carry a secondary explosive composition, and/or (b) each of the proximal, intermediate, and distal volumes of explosive media has an initiation sensitivity that is less than cyclotrimethylenetrinitramine (RDX) based explosive compositions.

Abstract: A system for controlling the jerk in an automatic/autonomous vehicle, said system comprising processing means, which comprise a jerk calculation module configured to acquire an electric acceleration signal and calculate a jerk value of said vehicle, and a plurality of operating modules, each configured to acquire an electric braking signal and said jerk value, one of said plurality of operating modules being selected by means of a selection signal, said selected module modifying the electric braking signal as a function of said jerk value and providing a modified electric braking signal to said braking system.

Abstract: A method of extracting metals from polymetallic sulphide ores or concentrates comprising at least Cu, Zn, Pb and Ag, comprising a first step of atmospheric leaching in sulphate medium in the presence of recycled silver for extracting Cu and Zn and a second step of atmospheric leaching in chloride medium for extracting Pb and Ag.

Abstract: Disclosed is a magazine apparatus including a first magazine and a second magazine. The first magazine is configured for holding, carrying and dispensing first initiation device components. The second magazine is configured for holding, carrying and dispensing second initiation device components. The first magazine and the second magazine are configured to dispense the first initiation device components and the second initiation device components in a corresponding manner such that a dispensed one of the first initiation device components and a correspondingly dispensed one of the second initiation device components can be assembled together to form a structurally complete, unified initiation device for loading into a borehole.

Abstract: Disclosed is a system that includes a magazine. The magazine is configured for holding and dispensing initiation devices or initiation device components having respective non-contact readable identification (ID) codes. The magazine includes one or more initiation device tracking unit(s) configured for reading the non-contact codes of the initiation devices or initiation device components for tracking the initiation devices or the initiation device components.

Abstract: The present invention provides an in vitro method for obtaining data useful for diagnosing a cardiomyopathy in a human subject, wherein the method comprises using, as an indicator, the expression levels, obtained from a biological sample isolated from the human subject, preferably a plasma sample, of one or more of the following miRNAs miR-721 and/or miR-155); and obtaining a result of the method by comparing the expression levels of said one or more miRNAs with a reference value or with the expression levels of a control, indicator of the absence of cardiomyopathy.

Abstract: An anti-exploitation application identifies and prevents a malicious action from occurring on a client. To do so, a monitoring system instantiated on the kernel of the operating system of the client. The monitoring system stores information describing actions taken by the processor. When the monitoring system detects a triggering action, it sends the triggering action to the anti-exploitation application to determine whether the triggering action is an exploitation action. The anti-exploitation application accesses an evidence set for the triggering action and its related actions. The anti-exploitation application generates an execution hierarchy defining the hierarchical relationships between the triggering action and its related actions and tests the hierarchy against a ruleset of grammatically structured rules. If a grammatically structured rule in the ruleset indicates that the triggering action is an exploitation action, the anti-exploitation application takes a prevention action.

Abstract: Drug conjugates of formula [D-(X)b-(AA)w-(L)-]n-Ab wherein: D is a drug moiety having the following formula (I) or a pharmaceutically acceptable salt, ester, solvate, tautomer or stereoisomer thereof, wherein: A is selected from R1, R2 and R3 is H, ORa, OCORa, OCOORa, alkyl, alkenyl, alkynyl, etc; R3? is, CORa, COORa, CONRaRb, etc; each of R4to R10 and R12 is alkyl, alkenyl or alkynyl; R11 is H, CORa, COORa, alkyl, alkenyl or alkynyl, or R11 and R12+N+C atoms to which they are attached may form a heterocyclic group; each of R13 and R14 is H, CORa, COORa, alkyl, alkenyl or alkynyl; each Ra and Rb is H, alkyl, alkenyl, alkynyl, etc.

Abstract: The invention relates to a method which comprises making a hole in a metallic support of an absorber tube, putting a vacuum pump in fluid communication with the chamber of the absorber tube by means of the hole, actuating the vacuum pump to generate a vacuum in the chamber until reaching a predetermined vacuum threshold, and introducing an inert gas inside the chamber and performing a plurality of sweeps with said inert gas, removing hydrogen from the chamber, allowing to thus reduce or remove the accumulation of hydrogen in said chamber, such that, as a result, at least part of the hydrogen absorption capacity of the getter material is recovered.

Abstract: Drug conjugates of formula [D-(X)b-(AA)w-(L)-]n-Ab wherein: D is a drug moiety having the following formula (I) or a pharmaceutically acceptable salt, ester, solvate, tautomer or stereoisomer thereof, wherein: A is selected from (II) and (III) R1, R2 and R3 is H, ORa, OCORa, OCO—ORa, alkyl, alkenyl, alkynyl, etc.; R3? is, CORa, COORa, CONRaRb, etc; each of R4 to R10 and R12 is alkyl, alkenyl or alkynyl; R11 is H, CORa, COORa, alkyl, alkenyl or alkynyl, or R11 and R12+N+C atoms to which they are attached may form a heterocyclic group; each of R13 and R14 is H, CORa, COORa, alkyl, alkenyl or alkynyl; each Ra and Rb is H, alkyl, alkenyl, alkynyl, etc.